⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1446922 | 0.85 | CA2 (0.38) | — | |
| SCHEMBL7995038 | 0.85 | CA2 (0.38) | — | |
| SCHEMBL10373641 | 0.81 | CA2 (0.31) | — | |
| Acetic Acid SCHEMBL3415860 | 0.80 | KMT2A (0.36) | — | |
| SCHEMBL6323265 | 0.79 | SIGMAR1 (0.30) | — | |
| Hypophosphorous Acid SCHEMBL5002567 | 0.78 | CA2 (0.33) | — | |
| SCHEMBL8038159 | 0.77 | PHGDH (0.33) | — | |
| SCHEMBL28434277 | 0.77 | SIGMAR1 (0.39) | — | |
| SCHEMBL4580801 | 0.75 | CA2 (0.32) | — | |
| SCHEMBL8993114 | 0.74 | KDM4E (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260041776-A1 | POLYMER CONTRAST AGENT | KOWA COMPANY, LTD. (JP) | 2026-02-12 | — | — | US | claimed |
| EP-4570837-A1 | POLYMER CONTRAST AGENT | KOWA COMPANY, LTD. (JP) | 2025-06-18 | — | — | EP | claimed |
| WO-2024034686-A1 | POLYMER CONTRAST AGENT | 興和株式会社 | 2024-02-15 | — | — | WO | claimed |
| US-20020176823-A1 | 1,4,7,10-tetraazacyclododecane butyltriols, processes for their production and pharmaceutical agents containing them | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2002-11-28 | — | — | US | claimed |
| US-6399043-B1 | RADIOLABELED MACROCYCLIC GADOLINIUM COMPLEXES WITH SUBSTANTIALLY BETTER NEURAL COMPATIBILITY; ENHANCED SIGNAL INTENSITY FOR NUCLEAR SPIN TOMOGRAPHY; WATER SOLUBILITY AND LOW OSMOLALITY; STABLE; NMR; RADIOIMAGING | SCHERING AKTIENGESELLSCHAFT (DE) | 2002-06-04 | — | — | US | claimed |
| US-20260041776-A1 | POLYMER CONTRAST AGENT | KOWA COMPANY, LTD. (JP) | 2026-02-12 | — | — | US | disclosed |
| EP-4570837-A1 | POLYMER CONTRAST AGENT | KOWA COMPANY, LTD. (JP) | 2025-06-18 | — | — | EP | disclosed |
| WO-2024034686-A1 | POLYMER CONTRAST AGENT | 興和株式会社 | 2024-02-15 | — | — | WO | disclosed |
| US-20060078503-A1 | 1,4,7,10-Tetraazacyclododecane butyltriols, processes for their production and pharmaceutical agents containing them | PLATZEK JOHANNES | 2006-04-13 | — | — | US | disclosed |
| US-6951639-B2 | 1,4,7,10-tetraazacyclododecane butyltriols, processes for their production and pharmaceutical agents containing them | SCHERING AG (DE) | 2005-10-04 | — | — | US | disclosed |
| US-20020176823-A1 | 1,4,7,10-tetraazacyclododecane butyltriols, processes for their production and pharmaceutical agents containing them | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2002-11-28 | — | — | US | disclosed |
| US-6399043-B1 | RADIOLABELED MACROCYCLIC GADOLINIUM COMPLEXES WITH SUBSTANTIALLY BETTER NEURAL COMPATIBILITY; ENHANCED SIGNAL INTENSITY FOR NUCLEAR SPIN TOMOGRAPHY; WATER SOLUBILITY AND LOW OSMOLALITY; STABLE; NMR; RADIOIMAGING | SCHERING AKTIENGESELLSCHAFT (DE) | 2002-06-04 | — | — | US | disclosed |
| US-5980864-A | 1,4,7,10-tetraazacyclododecane butyltriols, processes for their production and pharmaceutical agents containing them | SCHERING AKTIENGELLSELLSCHAFT (DE) | 1999-11-09 | — | — | US | disclosed |